Meritage Pharma

Phase III-ready rare disease drug for gastrointestinal and atopic diseases

placeSan Diego, California, United States calendar_todayFounded 2008 groups6 employees language meritagepharma.com

Innovation

16 patent families (9 granted) — focus: Human necessities, Physics & computing; filing pace slowing. Cited 4,137 times.

YearFilings
20123
20132
20145
20153
20164
20172
20183
20194
20203
20215
20222
20241

Investor mix

5 investors on record.

Investor typeCountShare
Venture capital480%
Other / undisclosed120%
Coming soon